Biotech News

Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook

Sientra (SIEN)Sientra2026-06-25 13:46 ESTEarnings

SIEN (SIEN) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is sien.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

SIENSientra2026-06-25 13:46 EST

Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander

SIENSientra2026-06-25 13:46 EST

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

SIENSientra2026-06-25 13:46 EST

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SIENSientra2026-06-25 13:46 EST

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

SIENSientra2026-06-25 13:46 EST

Sientra Reports Record Second Quarter Financial and Operational Results

SIENSientra2026-06-25 13:46 EST

Sientra to Present at the Stifel 2023 Healthcare Conference

SIENSientra2026-06-25 13:46 EST

Sientra Reports Third Quarter Financial and Operational Results

SIENSientra2026-06-25 13:46 EST

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

SIENSientra2026-06-25 13:46 EST

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

View all latest news

Sientra

Sientra is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

SIENSientra2026-06-26 11:26 EST

Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander

SIENSientra2026-06-26 11:26 EST

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

SIENSientra2026-06-26 11:26 EST

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SIENSientra2026-06-26 11:26 EST

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

SIENSientra2026-06-26 11:26 EST

Sientra Reports Record Second Quarter Financial and Operational Results

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States